Syngene International

Biocon files IPO prospectus for R&D arm Syngene to raise Rs 600 cr

The company plans to sell 22 million equity shares, including reservation of up to two million shares for Biocon shareholders, through an offer for sale.

FDI proposals worth Rs1,310 crore cleared

The government has approved 14 proposals of foreign direct investment (FDI) amounting to Rs.1,310.60 crore.<br /><br />

Biocon stock zooms after Silver Leaf Oak buys 10% stake in Syngene for Rs 380 cr

Mauritius-based private equity fund Silver Leaf Oak will acquire 10 per cent stake in Biocon's research services arm Syngene International for Rs 380 crore.